F Imamura

Summary

Country: Japan

Publications

  1. ncbi request reprint Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase
    F Imamura
    Department of Pulmonary Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Higashinari ku, Osaka 537 8511, Japan
    Jpn J Cancer Res 91:811-6. 2000
  2. ncbi request reprint Primary primitive neuroectodermal tumor of the lung: report of two cases
    F Imamura
    Department of Pulmonary Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan
    Lung Cancer 27:55-60. 2000
  3. ncbi request reprint Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA)
    M Mukai
    Department of Tumor Biochemistry, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan
    Int J Cancer 81:918-22. 1999
  4. ncbi request reprint Involvement of small GTPases Rho and Rac in the invasion of rat ascites hepatoma cells
    F Imamura
    Department of Pulmonary Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan
    Clin Exp Metastasis 17:141-8. 1999
  5. ncbi request reprint Cooperation of fibronectin with lysophosphatidic acid induces motility and transcellular migration of rat ascites hepatoma cells
    M Ayaki
    Department of Tumor Biochemistry, Osaka Medical Center for Cancer and Cardiovascular Diseases, 3 3 Nakamichi 1 Chome, Higashinari ku, 537 8511, Osaka, Japan
    Biochim Biophys Acta 1495:40-50. 2000
  6. ncbi request reprint Hepatoma cell migration through a mesothelial cell monolayer is inhibited by cyclic AMP-elevating agents via a Rho-dependent pathway
    M Mukai
    Department of Tumor Biochemistry, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
    FEBS Lett 484:69-73. 2000
  7. ncbi request reprint Detection of bone marrow metastases of small cell lung cancer with magnetic resonance imaging: early diagnosis before destruction of osseous structure and implications for staging
    F Imamura
    Department of Pulmonary Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1 3 3 Nakamichi, Higashinari ku, Osaka, Japan
    Lung Cancer 27:189-97. 2000
  8. ncbi request reprint Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: relation of the in vitro chemosensitive test to clinical response
    M Higashiyama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537 8511, Japan
    Oncol Rep 8:279-83. 2001
  9. ncbi request reprint [Surgical treatment for the second double lung cancers following chemotherapy for small cell lung cancer]
    T Momozane
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
    Kyobu Geka 62:117-21. 2009

Detail Information

Publications9

  1. ncbi request reprint Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase
    F Imamura
    Department of Pulmonary Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Higashinari ku, Osaka 537 8511, Japan
    Jpn J Cancer Res 91:811-6. 2000
    ..Y-27632 suppressed LPA-induced tyrosine phosphorylation of FAK and paxillin, suggesting that ROCK regulates these molecules and Y-27632 inhibits cellular migration and morphological change, at least in part, through this regulation...
  2. ncbi request reprint Primary primitive neuroectodermal tumor of the lung: report of two cases
    F Imamura
    Department of Pulmonary Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan
    Lung Cancer 27:55-60. 2000
    ..Both patients were successfully treated by the combination of surgical resection and chemotherapy, and are alive with no sign of recurrence for approximately 22 months in case 1 and 16 months in case 2...
  3. ncbi request reprint Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA)
    M Mukai
    Department of Tumor Biochemistry, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan
    Int J Cancer 81:918-22. 1999
    ..It also suppressed the pulmonary metastasis of B16 mouse melanoma cells injected into the tail vein of C57BL/6 mice. Thus, Pal-cLPA is effective in inhibiting invasion and metastasis of a variety of tumor cells...
  4. ncbi request reprint Involvement of small GTPases Rho and Rac in the invasion of rat ascites hepatoma cells
    F Imamura
    Department of Pulmonary Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan
    Clin Exp Metastasis 17:141-8. 1999
    ..We propose that Rho activation is not mediated by Rac but the cooperation of both GTPases is essential to trigger the invasive behavior of MM1 cells...
  5. ncbi request reprint Cooperation of fibronectin with lysophosphatidic acid induces motility and transcellular migration of rat ascites hepatoma cells
    M Ayaki
    Department of Tumor Biochemistry, Osaka Medical Center for Cancer and Cardiovascular Diseases, 3 3 Nakamichi 1 Chome, Higashinari ku, 537 8511, Osaka, Japan
    Biochim Biophys Acta 1495:40-50. 2000
    ....
  6. ncbi request reprint Hepatoma cell migration through a mesothelial cell monolayer is inhibited by cyclic AMP-elevating agents via a Rho-dependent pathway
    M Mukai
    Department of Tumor Biochemistry, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
    FEBS Lett 484:69-73. 2000
    ..Moreover, pull-down assays for GTP-bound, active RhoA demonstrated that the blockage by cAMP-elevating agents of morphological changes leading to the migration was probably mediated through inhibiting RhoA activation...
  7. ncbi request reprint Detection of bone marrow metastases of small cell lung cancer with magnetic resonance imaging: early diagnosis before destruction of osseous structure and implications for staging
    F Imamura
    Department of Pulmonary Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1 3 3 Nakamichi, Higashinari ku, Osaka, Japan
    Lung Cancer 27:189-97. 2000
    ..These results mean that almost all lesions in skeletal scintigraphy derived from bone marrow metastases. Furthermore, appreciable volume of cancer cells is present in bone marrow before osteolytic changes appear in skeletal scintigraphy...
  8. ncbi request reprint Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: relation of the in vitro chemosensitive test to clinical response
    M Higashiyama
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537 8511, Japan
    Oncol Rep 8:279-83. 2001
    ....
  9. ncbi request reprint [Surgical treatment for the second double lung cancers following chemotherapy for small cell lung cancer]
    T Momozane
    Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
    Kyobu Geka 62:117-21. 2009
    ..Careful follow-up especially focusing on 2nd primary lung cancer development is necessary for patients after successful treatment for small cell lung cancer...